Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Antony – page 2

49 clinical trials in Antony, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Antony at a glance
49
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

49 trials in Antony

Open in trial search

Dermatitis atopic

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Psoriasis

Not yet recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen - Cilag International
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive

Dermatitis atopic

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:0–17 years
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriasis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Neurodermatitis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Dermatitis atopic

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sasanlimab
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Antony

What the registry says about research in the country

01 Dermatological Conditions

Extensive research focusing on plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Multiple trials are evaluating novel therapeutic approaches for managing these chronic skin conditions.

  • Psoriasis Management Studies
  • Atopic Dermatitis Treatments
  • Hidradenitis Suppurativa Therapies

Several innovative treatments are being tested to improve patient outcomes and quality of life.

02 Oncology Research

Ongoing investigations into treatments for colorectal cancer, multiple myeloma, and bladder cancer. Studies include targeted therapies and novel treatment combinations.

  • Advanced Colorectal Cancer Treatments
  • Multiple Myeloma Therapies
  • Bladder Cancer Interventions

Focus on developing personalized treatment approaches for various cancer types.

03 Respiratory Medicine

Research centered on severe asthma treatment options, particularly focusing on patients with eosinophilic phenotype. Studies are evaluating new biological therapies and treatment comparisons.

  • Severe Asthma Management
  • Biological Therapy Evaluation
  • Treatment Response Assessment

Emphasis on developing targeted therapies for specific asthma phenotypes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.